Showing results (321-330 of 445) with videos related to

Sort By:
Pageof 45
Stem Cells Translational Medicine|March 17, 2023
Feasibility Study of Cord Tissue Derived Mesenchymal Stromal Cells in COVID-19-Related Acute Respiratory Distress SyndromeBeth H Shaz, Bryan D Kraft, Jesse D Troy, et al.
The New England Journal of Medicine|April 7, 1988
Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantationS J Brandt, W P Peters, S K Atwater, et al.
The American Journal of Pathology|March 1, 1988
Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-mycH S Friedman, P C Burger, S H Bigner, et al.
Orphanet Journal of Rare Diseases|February 3, 2018
Consensus guidelines for newborn screening, diagnosis and treatment of infantile Krabbe diseaseJennifer M Kwon, Dietrich Matern, Joanne Kurtzberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 8, 2017
Umbilical Cord Blood Transplantation in Children with Acute Leukemia: Impact of Conditioning on Transplantation OutcomesMary Eapen, Joanne Kurtzberg, Mei-Jie Zhang, et al.
Molecular Genetics and Metabolism|April 9, 2021
Consensus recommendations for the classification and long-term follow up of infants who screen positive for Krabbe DiseaseRobert Thompson-Stone, Margie A Ream, Michael Gelb, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignanciesJ Kurtzberg, T J Ernst, M J Keating, et al.
Leukemia|March 17, 2000
Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: a Pediatric Oncology Group reportJ H Laver, J C Barredo, M Amylon, et al.
Blood|April 20, 2007
Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201Allen R Chauvenet, Paul L Martin, Meenakshi Devidas, et al.
Journal of Pediatric Hematology/Oncology|November 1, 1996
Phase I trial and pharmacokinetic (PK) and pharmacodynamics (PD) study of topotecan using a five-day course in children with refractory solid tumors: a pediatric oncology group studyD G Tubergen, C F Stewart, C B Pratt, et al.
Pageof 45